As evidence mounts that antiretrovirals (ARVs) are effective for HIV prevention, policymakers and program managers will need to determine whether and how best to introduce specific products into health care systems. Determining the most appropriate users within a particular country will depend on the overall context, the nature of the HIV epidemic within the country, and the opportunities available to reach and serve HIV-negative women with ARV-based prevention products and services. This toolkit was developed by the Population Council for use by governments, organizations, and donors who are in a position to support or add new HIV-prevention products into programs. The toolkit was designed to help identify strategic opportunities for providing ARV-based products to women. The most effective mix of program entry points and delivery channels will vary from country to country. Similarly, the particular role a given product will play in a country will depend on a range of epidemiological, health system, and economic factors.
Population Council. 2015. "Introducing antiretroviral (ARV)-based prevention products for women: A guide to strategic decisionmaking and planning." New York: Population Council.